News

Aave has overhauled its asset listing standards following a $230 million exploit involving rsETH that exposed vulnerabilities in bridge infrastructure. The protocol is updating its risk framework to tighten requirements for assets that rely on cross-chain bridges. The move is a direct response to the incident, which highlighted systemic risks in DeFi collateral backed by bridged tokens.

China's antitrust regulator has reportedly requested additional information regarding the proposed deal between Kenvue and Kimberly-Clark, according to a SeekingAlpha report. The request for more information typically signals a more in-depth review by Chinese authorities and could delay deal closure. No further details on the scope of the inquiry or a revised timeline were provided.

Hengli Petrochemical, a major Chinese refiner, has publicly denied conducting trade with Iran following the imposition of US sanctions. The denial comes in direct response to pressure from US authorities targeting companies alleged to be involved in Iranian oil trade. No further details on the scope or specifics of the sanctions have been confirmed in this report.

US authorities have frozen $344 million in crypto assets linked to Iran, with the action occurring one day after Tether confirmed it froze an equivalent amount of its USDt stablecoin at the request of US law enforcement. The move highlights continued regulatory and enforcement pressure on stablecoin issuers to comply with government sanctions and asset-freeze requests. Tether's cooperation with authorities underscores the compliance obligations facing centralized stablecoin operators.

Regeneron has reached a drug pricing agreement with the Trump administration, becoming the latest major pharmaceutical company to make pricing concessions. As part of the deal, Regeneron will offer its new hearing-loss therapy at no cost. The agreement follows a broader pattern of drugmakers negotiating pricing arrangements with the administration.